Want to join the conversation?
$FFIV 3Q15 Call: Revenue of $483.6MM grew 2% from 2Q15 and 10% YoverY and was at the high end of $475-485MM guided range. GAAP EPS of $1.29 per share was above guidance of $1.16-1.19 per share. Strength in EPS was driven by solid revenue and operating margin results and lower-than-expected tax rate during the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?